Bay Street News, October 12th, 2020

TEL AVIV, Israel, Oct. 12, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), today announced that the European Patent Office (EPO) […]

–Data validate physiologically relevant assay used in MORF-057 Phase 1 studies to measure receptor occupancy of α4β7integrin–-MORF-057, inhibitor of α4β7integrin, […]

NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) —  BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused […]

BOCA RATON, Fla., Oct. 12, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of […]

SAN JOSE, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) — DSP Group, Inc. (NASDAQ: DSPG), a leading global provider of wireless and voice-processing […]

Aileron aims to create new paradigm of proactive prevention of chemotherapy-induced side effects to address significant unmet need among cancer […]

Four abstracts from the OV101 (gaboxadol) clinical development program in Angelman Syndrome and Fragile X Syndrome to be presentedNEW YORK, […]

PHOENIX, Oct. 12, 2020 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for September 2020.Mesa [...]

WATERTOWN, Mass., Oct. 12, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation […]

CHICAGO, Oct. 12, 2020 (GLOBE NEWSWIRE) — Suzanne Clark, TransUnion (NYSE: TRU) board member and President of the U.S. Chamber […]